전체메뉴
검색
Article Search

JMB Journal of Microbiolog and Biotechnology

QR Code QR Code

Research article


References

  1. Quigley E. 2009. Gut permeability in irritable bowel syndrome: More leaks add to slightly inflamed bowel syndrome conspiracy theory. Gastroenterology 137: 728-730.
  2. Gracie DJ, Ford AC. 2017. Irritable bowel syndrome-type symptoms are associated with psychological comorbidity, reduced quality of life, and health care use in patients with inflammatory bowel disease. Gastroenterology 153: 324-325.
  3. Spiller R, Garsed K. 2009. Postinfectious irritable bowel syndrome. Gastroenterology 136: 1979-1988.
  4. Orr WC, Crowell MD, Lin B, Harnish MJ, Chen JD. 1997. Sleep and gastric function in irritable bowel syndrome: derailing the braingut axis. Gut 41: 390-393.
  5. Botschuijver S, Roeselers G, Levin E, Jonkers DM, Welting O, Heinsbroek SEM, et al. 2017. Intestinal fungal dysbiosis is associated with visceral hypersensitivity in patients with irritable bowel syndrome and rats. Gastroenterology 153: 1026-1039.
  6. Kellow JE, Phillips SF, Miller LJ, Zinsmeister AR. 1988. Dysmotility of the small intestine in irritable bowel syndrome. Gut 29: 12361243.
  7. Sasaki D, Sutoh T, Abe T. 1992. Psychosomatic treatment of irritable bowel syndrome. Nihon Rinsho 50: 2758-2763.
  8. Drossman DA, McKee DC, Sandler RS, Mitchell CM, Cramer EM, Lowman BC, et al. 1988. Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 95: 701-708.
  9. Zhang H, Sun J, Liu X, Hong C, Zhu Y, Liu A, et al. 2013. Lactobacillus paracasei subsp. Paracasei lc01 positively modulates intestinal microflora in healthy young adults. J. Microbiol. 51: 777-782.
  10. Zhang H, Wang Y, Sun J, Guo Z, Guo H, Ren F. 2013. Safety evaluation of Lactobacillus paracasei subsp. paracasei LC-01, a probiotic bacterium. J. Microbiol. 51: 633-638.
  11. Pahumunto N, Sophatha B, Piwat S, Teanpaisan R. 2019. Increasing salivary IgA and reducing Streptococcus mutans by probiotic Lactobacillus paracasei SD1: A double-blind, randomized, controlled study. J. Dent Sci. 14: 178-184.
  12. Marttinen AM, Haukioja AL, Keskin M, Soderling EM. 2013. Effects of Lactobacillus reuteri PTA 5289 and L. paracasei DSMZ16671 on the adhesion and biofilm formation of Streptococcus mutans. Curr. Microbiol. 67: 193-199.
  13. Zhou Q, Verne GN. 2011. Mirna-based therapies for the irritable bowel syndrome. Expert Opin. Biol. Ther. 11: 991-995.
  14. Zhou Q, Souba WW, Croce CM, Verne GN. 2010. Microrna-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome. Gut 59: 775-784.
  15. Ye D, Guo S, Al-Sadi R, Ma TY. 2011. Microrna regulation of intestinal epithelial tight junction permeability. Gastroenterology 141:1323-1333.
  16. Zhang L, Shen J, Cheng J, Fan X. 2015. MicroRNA-21 regulates intestinal epithelial tight junction permeability. Cell Biochem. Funct. 33: 235-240.
  17. Hou Q, Huang Y, Zhu S, Li P, Chen X, Hou Z, et al. 2017. MiR-144 increases intestinal permeability in IBS-D rats by targeting OCLN and ZO1. Cell Physiol. Biochem. 44: 2256-2268.
  18. Compare D, Rocco A, Coccoli P, Angrisani D, Sgamato C, Iovine B, et al. 2017. Lactobacillus casei dg and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome. BMC Gastroenterol. 17: 53.
  19. Lin X, Chen X, Tu Y, Wang S, Chen H. 2017. Effect of probiotic lactobacilli on the growth of streptococcus mutans and multispecies biofilms isolated from children with active caries. Med. Sci. Monit. 23: 4175-4181.
  20. Williams MR, Stedtfeld RD, Tiedje JM, Hashsham SA. 2017. Micrornas-based inter-domain communication between the host and members of the gut microbiome. Front. Microbiol. 8: 1896.
  21. Singh N, Shirdel EA, Waldron L, Zhang RH, Jurisica I, Comelli EM. 2012. The murine caecal microrna signature depends on the presence of the endogenous microbiota. Int. J. Biol. Sci. 8: 171-186.
  22. Dalmasso G, Nguyen HT, Yan Y, Laroui H, Charania MA, Ayyadurai S, et al. 2011. Microbiota modulate host gene expression via micrornas. PLoS One 6: e19293.
  23. Peterson LW, Artis D. 2014. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat. Rev. Immunol. 14:141-153.
  24. Pruteanu M, Shanahan F. 2013. Digestion of epithelial tight junction proteins by the commensal clostridium perfringens. Am. J. Physiol. Gastrointest. Liver Physiol. 305: G740-748.
  25. Liu C, Duan Z, Guan Y, Wu H, Hu K, Gao X, et al. 2018. Increased expression of tight junction protein occludin is associated with the protective effect of mosapride against aspirin-induced gastric injury. Exp. Ther. Med. 15: 1626-1632.
  26. Ye L, Martin TA, Parr C, Harrison GM, Mansel RE, Jiang WG. 2003. Biphasic effects of 17-beta-estradiol on expression of occludin and transendothelial resistance and paracellular permeability in human vascular endothelial cells. J. Cell. Physiol. 196: 362-369.
  27. Caswell D, Jaggi S, Axis J, Amsler K. 2013. Src family kinases regulate renal epithelial paracellular permeability barrier through an occludin-independent mechanism. J. Cell. Physiol. 228: 1210-1220.
  28. Buret AG, Mitchell K, Muench DG, Scott KG. 2002. Giardia lamblia disrupts tight junctional zo-1 and increases permeability in nontransformed human small intestinal epithelial monolayers: effects of epidermal growth factor. Parasitology 125: 11-19.
  29. Cario E, Gerken G, Podolsky DK. 2004. Toll-like receptor 2 enhances zo-1-associated intestinal epithelial barrier integrity via protein kinase c. Gastroenterology 127: 224-238.

Related articles in JMB

More Related Articles